Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 7
1969 1
1970 2
1971 5
1972 9
1973 6
1974 10
1975 9
1976 8
1977 11
1978 9
1979 7
1980 9
1981 5
1982 6
1983 17
1984 19
1985 21
1986 33
1987 26
1988 14
1989 24
1990 17
1991 21
1992 22
1993 27
1994 33
1995 32
1996 39
1997 20
1998 36
1999 21
2000 25
2001 28
2002 27
2003 37
2004 41
2005 23
2006 26
2007 16
2008 21
2009 38
2010 23
2011 15
2012 27
2013 21
2014 23
2015 29
2016 34
2017 19
2018 23
2019 26
2020 25
2021 10
2022 6
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

1,060 results

Results by year

Filters applied: . Clear all
Page 1
Oral Anticoagulation.
Altiok E, Marx N. Altiok E, et al. Dtsch Arztebl Int. 2018 Nov 16;115(46):776-783. doi: 10.3238/arztebl.2018.0776. Dtsch Arztebl Int. 2018. PMID: 30602410 Free PMC article. Review.
RESULTS: The main indications for oral anticoagulation are atrial fibrillation, venous thromboembolism, and status post heart valve replacement. In patients with atrial fibrillation and without valvular heart disease, anticoagulation is r …
RESULTS: The main indications for oral anticoagulation are atrial fibrillation, venous thromboembolism, and status post hea …
Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial.
Chu MWA, Ruel M, Graeve A, Gerdisch MW, Damiano RJ Jr, Smith RL 2nd, Keeling WB, Wait MA, Hagberg RC, Quinn RD, Sethi GK, Floridia R, Barreiro CJ, Pruitt AL, Accola KD, Dagenais F, Markowitz AH, Ye J, Sekela ME, Tsuda RY, Duncan DA, Swistel DG, Harville LE 3rd, DeRose JJ, Lehr EJ, Alexander JH, Puskas JD; PROACT Mitral Investigators. Chu MWA, et al. Ann Thorac Surg. 2023 Apr;115(4):929-938. doi: 10.1016/j.athoracsur.2022.12.031. Epub 2023 Jan 4. Ann Thorac Surg. 2023. PMID: 36610532 Clinical Trial.
The primary end point was the sum of the linearized rates of thromboembolism, valve thrombosis, and bleeding events. The design was based on an expected 7.3% event rate and 1.5% noninferiority margin. ...Rates (percentage per patient-year) of the individual componen …
The primary end point was the sum of the linearized rates of thromboembolism, valve thrombosis, and bleeding events. The desig …
Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis.
Passaglia LG, de Barros GM, de Sousa MR. Passaglia LG, et al. J Thromb Haemost. 2015 Sep;13(9):1557-67. doi: 10.1111/jth.13047. Epub 2015 Jul 29. J Thromb Haemost. 2015. PMID: 26178802 Free article. Review.
OBJECTIVE: To perform a systematic review and meta-analysis of studies evaluating anticoagulation during the early postoperative period following mechanical heart valve implantation. METHODS: Five literature databases were searched to assess the rates of blee …
OBJECTIVE: To perform a systematic review and meta-analysis of studies evaluating anticoagulation during the early postoperative peri …
Dabigatran versus warfarin in patients with mechanical heart valves.
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van de Werf F; RE-ALIGN Investigators. Eikelboom JW, et al. N Engl J Med. 2013 Sep 26;369(13):1206-14. doi: 10.1056/NEJMoa1300615. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991661 Free article. Clinical Trial.
We evaluated the use of dabigatran in patients with mechanical heart valves. METHODS: In this phase 2 dose-validation study, we studied two populations of patients: those who had undergone aortic- or mitral-valve replacement within the past 7 days and those who had …
We evaluated the use of dabigatran in patients with mechanical heart valves. METHODS: In this phase 2 dose-validation study, we studi …
New Oral Anticoagulation after Heart Valve Replacement.
El-Battrawy I, Baumann S, Huseynov A, Akin I. El-Battrawy I, et al. Cardiovasc Hematol Disord Drug Targets. 2015;15(2):106-9. doi: 10.2174/1871529x1502151209111735. Cardiovasc Hematol Disord Drug Targets. 2015. PMID: 26666327 Review.
Since in the early 1960s, oral anticoagulation with vitamin K antagonist are the gold-standard for prevention of thromboembolism at replaced heart valves. ...Further studies are required to evaluate the several newer oral anticoagulations in patients w …
Since in the early 1960s, oral anticoagulation with vitamin K antagonist are the gold-standard for prevention of thromboembolism …
Bridging Anticoagulation with Mechanical Heart Valves: Current Guidelines and Clinical Decisions.
Ali M, Becker RC. Ali M, et al. Curr Cardiol Rep. 2020 Sep 10;22(11):130. doi: 10.1007/s11886-020-01390-2. Curr Cardiol Rep. 2020. PMID: 32910313 Review.
Results from the PERI-OP trial of patients with either a mechanical heart valve, atrial fibrillation, or atrial flutter requiring interruption of oral anticoagulant therapy for surgery will inform clinical practice. Patient-specific factors and valve-s …
Results from the PERI-OP trial of patients with either a mechanical heart valve, atrial fibrillation, or atrial flutter requir …
INR variability and outcomes in patients with mechanical heart valve prosthesis.
Labaf A, Själander A, Stagmo M, Svensson PJ. Labaf A, et al. Thromb Res. 2015 Dec;136(6):1211-5. doi: 10.1016/j.thromres.2015.10.044. Epub 2015 Oct 31. Thromb Res. 2015. PMID: 26558830
BACKGROUND: The quality of treatment with warfarin is mainly assessed by the time in therapeutic range (TTR) in patients with mechanical heart valve prosthesis (MHV). Our aim was to evaluate if International Normalized Ratio (INR) variability predicted a comb …
BACKGROUND: The quality of treatment with warfarin is mainly assessed by the time in therapeutic range (TTR) in patients with mechanical …
Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Massel DR, Little SH. Massel DR, et al. Cochrane Database Syst Rev. 2013 Jul 9;2013(7):CD003464. doi: 10.1002/14651858.CD003464.pub2. Cochrane Database Syst Rev. 2013. PMID: 23839768 Free PMC article. Review.
BACKGROUND: Patients with prosthetic heart valves are at increased risk for valve thrombosis and arterial thromboembolism. ...SELECTION CRITERIA: All reports of randomised controlled trials comparing standard-dose oral anticoagulation to standard-dose …
BACKGROUND: Patients with prosthetic heart valves are at increased risk for valve thrombosis and arterial thromboembolism …
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
Grzymala-Lubanski B, Svensson PJ, Renlund H, Jeppsson A, Själander A. Grzymala-Lubanski B, et al. Heart. 2017 Feb;103(3):198-203. doi: 10.1136/heartjnl-2016-309585. Epub 2016 Sep 2. Heart. 2017. PMID: 27590664
OBJECTIVES: To study the impact of time in therapeutic range (TTR) and international normalised ratio (INR) variability on the risk of thromboembolic events, major bleeding complications and death after mechanical heart valve (MHV) implantation. ...METHODS: A …
OBJECTIVES: To study the impact of time in therapeutic range (TTR) and international normalised ratio (INR) variability on the risk of th …
Impact of an oral anticoagulation self-monitoring and self-management program in patients with mechanical heart valve prosthesis.
Blanch P, Freixa-Pamias R, Gambau M, Lafuente R, Basile L. Blanch P, et al. J Comp Eff Res. 2021 Mar;10(4):307-314. doi: 10.2217/cer-2020-0215. Epub 2021 Feb 17. J Comp Eff Res. 2021. PMID: 33594899 Free article.
Objective: To analyze impact of implementation of an oral anticoagulation self-monitoring and self-management program among patients with mechanical valve prosthesis. ...Conclusion: Oral anticoagulation self-monitoring and self-management program seems …
Objective: To analyze impact of implementation of an oral anticoagulation self-monitoring and self-management program among patients …
1,060 results